ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Havrix 720, Injektionssuspension - 
00599002 GlaxoSmithKline AG
Havrix 720, Injektionssuspension30.09.1996
  30.09.1996
Hepatitis A, Inactivated, Whole Virus (J07BC02) 
WHO-DDD 
08.08. 
08.08. 
B  
No 
IP 
PR  
k.A.PR
  
7680005990020Impfstoffe
  
Composition
Vaccinum adsorbatum: hepatitis-A-virus inactivatus (HM175) 720 U. corresp. proteina max. 0.2 µg, aluminii hydroxidum hydricum ad adsorptionem corresp. aluminium 0.25 mg, aminoacida cum phenylalaninum 83 µg, dinatrii phosphas, kalii dihydrogenophosphas, natrii chloridum, kalii chloridum, polysorbatum 20, aqua ad iniectabile, ad suspensionem pro 0.5 ml corresp. natrium max. 1.7 mg et kalium max. 0.2 mg, residui: neomycini sulfas.
Packungsbestandteile
Injection suspension
 
 
Active AgentDoseadditional_information
Hepatitis-A-Virus Inactivatus (Hm175)720U. / 0.5ml correspond Protein 0.2µg / 0.5mlVaccinum adsorbatum
 
Inactive agentsDose
Aluminii Hydroxidum Hydricum ad Adsorptionem 
Aminoacida cum Phenylalaninum83µg / 0.5ml
Disodium Phosphate 
Potassium Chloride 
Potassium Dihydrogenophosphate 
Sodium Chloride 
Polysorbatum 20 
Source
Data was imported : 08.08.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home